Tag: Endotronix

COVID-19: Optimising heart failure management in the patient’s home

Physicians recognised the importance of remote management for heart failure patients long before the COVID-19 pandemic. However, the current situation has heightened the urgency...

First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure...

Endotronix has announced the enrollment of the first two patients in the PROACTIVE-HF trial. The trial is a premarket investigational device exempt (IDE) study...

AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary...

Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor System at the 2019 American Heart Association (AHA) Scientific Sessions (16–18 November,...

Endotronix closes expanded series D financing round of US$70 million for...

Endotronix has announced the expansion of its series D financing round, bringing the total to US$70 million. The expansion syndicate includes new investment from...

Endotronix joins AHA’s Center for Health Technology & Innovation to broaden...

Endotronix has announced they have joined the American Heart Association’s Center for Health Technology & Innovation’s (CHTI) Innovators Network. The collaboration allows Endotronix to...

First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

Endotronix has announced successful first-in-human implantation of the Cordella pulmonary artery pressure sensor and the initiation of the SIRONA first-in-human (FIH) clinical trial. Wilfried...